RNAZ - Bathi operasional sadurunge ngurangi amortisasi transcodetherapeutics.com
TransCode Therapeutics (RNAZ) aims for the global implementation of RNA delivery systems to combat metastases, while building a vast array of patents and partnerships through innovative cancer cell penetration methods. Absolute EBITDA visualizes the financial trend, where the 0.00 metric reflects current dynamics. The final outcome depends on clinical trial results and strict capital management in the absence of profit.
TransCode Therapeutics, Inc. - rincian analitis lan metrik utama (RNAZ)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- data nilai buku modal saham:
- data tingkat utang lan likuiditas finansial:
Utang marang Modal TransCode Therapeutics|RNAZ - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal TransCode Therapeutics Inc.|RNAZ - Gunggung utang perusahaan|Utang marang modal buku TransCode Therapeutics|RNAZ - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan TransCode Therapeutics|Likuiditas darurat transcodetherapeutics.com
- rincian bathi lan kelipatan pasar:
RNAZ - Bathi resik perusahaan|Penghasilan resik sing dikarepake TransCode Therapeutics|RNAZ - Pangali P/E|Pangali Forward P/E TransCode Therapeutics Inc.|RNAZ - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan TransCode Therapeutics|RNAZ - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan TransCode Therapeutics|RNAZ - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan transcodetherapeutics.com|RNAZ - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep TransCode Therapeutics
Pambiji fundamental perusahaan:TransCode Therapeutics RNAZ
This indicator captures actual cash flows from core operations before accounting for tax and interest obligations, allowing for the identification of hidden cyclicality in cash inflows. Analyzing the EBITDA chronology on the GURU.Markets platform helps assess the sustainability of the model: for TransCode Therapeutics (RNAZ), the absence of sales turns this metric into a reflection of rising costs for preclinical research of RNA drugs, eliminating the influence of operating leverage.
Karo sapa TransCode Therapeutics saingan
Pendapatan operasional sadurunge ngurangi amortisasi Tempus (TEM)|Qiagen N.V. - Bathi operasional EBITDA|ionispharma.com (IONS) - Bathi operasional sadurunge ngurangi amortisasi|Repligen (RGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Avidity Biosciences Inc (RNA)|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi WGS (GeneDx Corp)|Bathi operasional EBITDA RARE|BEAM - Bathi sadurunge bunga, pajak, lan amortisasi|Sarepta - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TWST|TXG: Bathi operasional sadurunge ngurangi amortisasi|Intellia Corp - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|STOK: Bathi operasional EBITDA|biolifesolutions.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Maze Therapeutics, Inc. MAZE|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sionna Pharma (SION)|PRME (Prime Medicine Bio) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TSHA (Taysha Gene Therapies)|Bathi operasional EBITDA uniqure.com QURE|MGTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi RGNX|SLDB: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Ocugen Pharma (OCGN)|Bathi operasional sadurunge ngurangi amortisasi PACB|Bathi operasional EBITDA benitec.com|Bathi operasional sadurunge ngurangi amortisasi DSGN (Design Therapeutics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi RCKT|Bathi operasional EBITDA FDMT (4D Molecular Therapeutics Inc)|Pendapatan operasional sadurunge ngurangi amortisasi Lexeo Therapeutics Inc. (LXEO)|Korro Bio, Inc - Bathi operasional EBITDA|editasmedicine.com (EDIT) - Bathi operasional sadurunge ngurangi amortisasi|Silence Therapeutics plc (SLN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PRQR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Codexis Inc|SGMO: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nautilus Biotechnology (NAUT)|metagenomi.co - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA DTIL (Precision BioSciences, Inc.)|Bathi operasional EBITDA Generation Bio Co GBIO|BOLD: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi XCUR|IMNN: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi PHIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Mustang Bio Inc|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|ImmunoPrecise Antibodies Ltd. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi OMGA (omegatherapeutics.com)|OMIC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RGLS (Regulus Therapeutics, Inc.)|SYRS: Bathi operasional EBITDA|Telesis Bio, Inc (TBIO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|Bathi operasional sadurunge amortisasi UBX (unitybiotechnology.com)
